ImmBioApplying the science of ImmunoBiology to Healthcare
 

Press

  Dr Chris Bailey appointed as Development Director.
Thursday 10th Jun 2004

Dr Bailey was previously with Celltech and Medeva, where he was responsible for taking their Hepatitis B vaccine from laboratory, right through to European approval. This was the first recombinant vaccine product, manufactured in mammalian cells to be approved by the European Medicines Evaluation Agency (EMEA).